A monthly injection could halt rheumatoid arthritis (RA) in half of all patients, trial data suggests. The antibody drug tocilizumab works in conjunction with an existing treatment, methotrexate, to stop the condition in which the body attacks its own joints.
Link to Article
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment